GenScript

GenScript

Employees:
1,300
Market Cap:
$44.8 billion
Revenue:
$115 million
Net Income:
$200 million

GenScript

Employees:
1,300
Market Cap:
$44.8 billion
Revenue:
$115 million
Net Income:
$200 million
  • Dec 31 at 1:00 PM
    Thank you so much to everyone for your continued trust and support in 2017. See you in 2018! Happy New Year!
  • Dec 27 at 1:00 PM
    Neo-antigen discovery by an advanced method: http://ow.ly/ZlyC30hrA6O. T cell receptor (TCR) recognition of peptides on the human leukocyte antigen (HLA) determines T cell immune response. Therefore, identifying specific neoantigens for immunotherapy has attracted great attention both in academic laboratories and pharmaceutical companies. Now, Garcia and colleagues developed a novel method combining yeast display library screening and single-cell TCR characterization through sequencing, which was reported online in Cell. Compared to previous strategies, this approach is an unbiased and high-throughput manner due to the yeast display selection for enriching specific peptides. So, this technique will illuminate cellular details of T-cell mediated diseases. More importantly, it will be beneficial for the adoptive T cell therapies or vaccine design based on the identified neoantigens.
  • Dec 24 at 1:00 PM
  • Dec 24 at 1:00 PM

Dec 31, 1:00 PM

Thank you so much to everyone for your continued trust and support in 2017. See you in 2018! Happy New Year!

Dec 27, 1:00 PM

Neo-antigen discovery by an advanced method: http://ow.ly/ZlyC30hrA6O. T cell receptor (TCR) recognition of peptides on the human leukocyte antigen (HLA) determines T cell immune response. Therefore, identifying specific neoantigens for immunotherapy has attracted great attention both in academic laboratories and pharmaceutical companies. Now, Garcia and colleagues developed a novel method combining yeast display library screening and single-cell TCR characterization through sequencing, which was reported online in Cell. Compared to previous strategies, this approach is an unbiased and high-throughput manner due to the yeast display selection for enriching specific peptides. So, this technique will illuminate cellular details of T-cell mediated diseases. More importantly, it will be beneficial for the adoptive T cell therapies or vaccine design based on the identified neoantigens.

Dec 24, 1:00 PM

Dec 24, 1:00 PM

3 jobs at GenScript

Jobs in